Literature DB >> 25207186

Magnesium Therapy in Pre-eclampsia Prolongs Analgesia Following Spinal Anaesthesia with Fentanyl and Bupivacaine: An Observational Study.

Tülay Özkan Seyhan1, Olgaç Bezen2, Mukadder Orhan Sungur1, Ibrahim Kalelioğlu3, Meltem Karadeniz1, Kemalettin Koltka1.   

Abstract

BACKGROUND: Magnesium has anti-nociceptive effects and potentiates opioid analgesia following its systemic and neuraxial administration. However, there is no study evaluating the effects of intravenous (IV) magnesium sulphate (MgSO4) therapy on spinal anaesthesia characteristics in severely pre-eclamptic patients. AIMS: The aim of this study was to compare spinal anaesthesia characteristics in severely pre-eclamptic parturients treated with MgSO4 and healthy preterm parturients undergoing caesarean section. Thus, our primary outcome was regarded as the time to first analgesic request following spinal anaesthesia. STUDY
DESIGN: Case-control Study.
METHODS: Following approval of Institutional Clinical Research Ethics Committee and informed consent of the patients, 44 parturients undergoing caesarean section with spinal anaesthesia were enrolled in the study in two groups: Healthy preterm parturients (Group C) and severely pre-eclamptic parturients with IV MgSO4 therapy (Group Mg). Following blood and cerebrospinal fluid (CSF) sampling, spinal anaesthesia was induced with 9 mg hyperbaric bupivacaine and 20 μg fentanyl. Serum and CSF magnesium levels, onset of sensory block at T4 level, highest sensory block level, motor block characteristics, time to first analgesic request, maternal haemodynamics as well as side effects were evaluated.
RESULTS: Blood and CSF magnesium levels were higher in Group Mg. Sensory block onset at T4 were 257.1±77.5 and 194.5±80.1 sec in Group C and Mg respectively (p=0.015). Time to first postoperative analgesic request was significantly prolonged in Group Mg than in Group C (246.1±52.8 and 137.4±30.5 min, respectively, p<0.001; with a mean difference of 108.6 min and 95% CI between 81.6 and 135.7). Side effects were similar in both groups. Group C required significantly more fluids.
CONCLUSION: Treatment with IV MgSO4 in severe pre-eclamptic parturients significantly prolonged the time to first analgesic request compared to healthy preterm parturients, which might be attributed to the opioid potentiation of magnesium.

Entities:  

Keywords:  Caesarean section; magnesium sulphate; pre-eclampsia; spinal anaesthesia

Year:  2014        PMID: 25207186      PMCID: PMC4115934          DOI: 10.5152/balkanmedj.2014.13116

Source DB:  PubMed          Journal:  Balkan Med J        ISSN: 2146-3123            Impact factor:   2.021


  24 in total

1.  Changes in cerebrospinal fluid magnesium levels in patients undergoing spinal anaesthesia for hip arthroplasty: does intravenous infusion of magnesium sulphate make any difference? A prospective, randomized, controlled study.

Authors:  M Mercieri; R A De Blasi; S Palmisani; S Forte; P Cardelli; R Romano; G Pinto; R Arcioni
Journal:  Br J Anaesth       Date:  2012-06-01       Impact factor: 9.166

2.  A randomised study of magnesium sulphate as an adjuvant to intrathecal bupivacaine in patients with mild preeclampsia undergoing caesarean section.

Authors:  S Malleeswaran; N Panda; P Mathew; R Bagga
Journal:  Int J Obstet Anesth       Date:  2010-02-18       Impact factor: 2.603

Review 3.  Cerebral hemodynamics in preeclampsia: cerebral perfusion and the rationale for an alternative to magnesium sulfate.

Authors:  Michael A Belfort; Steven L Clark; Baha Sibai
Journal:  Obstet Gynecol Surv       Date:  2006-10       Impact factor: 2.347

Review 4.  Preeclampsia and anaesthesia.

Authors:  Wiebke Gogarten
Journal:  Curr Opin Anaesthesiol       Date:  2009-06       Impact factor: 2.706

5.  [Magnesium sulphate and severe preeclampsia: its use in current practice].

Authors:  B Girard; G Beucher; C Muris; T Simonet; M Dreyfus
Journal:  J Gynecol Obstet Biol Reprod (Paris)       Date:  2005-02

6.  The effect of adding magnesium sulphate to epidural bupivacaine and fentanyl in elective caesarean section using combined spinal-epidural anaesthesia: a prospective double blind randomised study.

Authors:  A A Yousef; Y M Amr
Journal:  Int J Obstet Anesth       Date:  2010-09-15       Impact factor: 2.603

7.  Magnesium sulfate does not reduce postoperative analgesic requirements.

Authors:  S H Ko; H R Lim; D C Kim; Y J Han; H Choe; H S Song
Journal:  Anesthesiology       Date:  2001-09       Impact factor: 7.892

8.  Plasma from preeclamptic women increases blood-brain barrier permeability: role of vascular endothelial growth factor signaling.

Authors:  Odül A Amburgey; Abbie C Chapman; Victor May; Ira M Bernstein; Marilyn J Cipolla
Journal:  Hypertension       Date:  2010-09-20       Impact factor: 10.190

9.  Intravenous magnesium sulfate for post-operative pain in patients undergoing lower limb orthopedic surgery.

Authors:  A Dabbagh; H Elyasi; S S Razavi; M Fathi; S Rajaei
Journal:  Acta Anaesthesiol Scand       Date:  2009-06-10       Impact factor: 2.105

10.  I.V. infusion of magnesium sulphate during spinal anaesthesia improves postoperative analgesia.

Authors:  J-Y Hwang; H-S Na; Y-T Jeon; Y-J Ro; C-S Kim; S-H Do
Journal:  Br J Anaesth       Date:  2010-01       Impact factor: 9.166

View more
  1 in total

Review 1.  Intravenous Magnesium Sulphate for Analgesia after Caesarean Section: A Systematic Review.

Authors:  Andrew McKeown; Vyacheslav Seppi; Raymond Hodgson
Journal:  Anesthesiol Res Pract       Date:  2017-12-03
  1 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.